4//SEC Filing
BIO-TECHNE Corp 4
Accession 0000914190-16-000764
$TECHCIK 0000842023operating
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 5:13 PM ET
Size
17.0 KB
Accession
0000914190-16-000764
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Gould Kevin S
SVP Clinical Controls
Transactions
- Award
Stock Options (Right to Buy)
2016-08-18+13,028→ 13,028 totalExercise: $106.59Exp: 2023-08-18→ Common Stock (13,028 underlying) - Award
Stock Options (Right to Buy)
2016-08-18+17,371→ 17,371 totalExercise: $106.59Exp: 2023-08-18→ Common Stock (17,371 underlying) - Award
Restricted Stock Units
2016-08-18+2,111→ 2,111 total→ Common Stock (2,111 underlying)
Holdings
- 10,000
Stock Options (Right to Buy)
Exercise: $88.23Exp: 2023-01-04→ Common Stock (10,000 underlying) - 2,191
Common Stock
- 50,000
Stock Options (Right to Buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (50,000 underlying) - 15,000
Stock Options (Right to Buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (15,000 underlying)
Footnotes (6)
- [F1]Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
- [F2]50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
- [F3]Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.
- [F4]Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- [F5]Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F6]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0000842023
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 5:13 PM ET
- Size
- 17.0 KB